Scarica l'app Stockscreener
81.04
1.98%
1.57
Dopo l'orario di chiusura:
81.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$79.47
Aprire:
$79.4
Volume 24 ore:
387.90K
Relative Volume:
0.99
Capitalizzazione di mercato:
$1.82B
Reddito:
$747.40M
Utile/perdita netta:
$-12.60M
Rapporto P/E:
-105.42
EPS:
-0.7687
Flusso di cassa netto:
$105.18M
1 W Prestazione:
+2.66%
1M Prestazione:
-0.37%
6M Prestazione:
+24.54%
1 anno Prestazione:
+49.63%
Intervallo 1D:
$78.05
$81.35
Intervallo di 1 settimana:
$76.69
$81.35
Portata 52W:
$52.73
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Nome
Ani Pharmaceuticals Inc
Settore
Telefono
(218) 634-3500
Indirizzo
210 MAIN STREET WEST, BAUDETTE, MN
Confronta ANIP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
81.04 | 1.78B | 747.40M | -12.60M | 105.18M | -0.7687 |
|
ZTS
Zoetis Inc
|
126.85 | 55.38B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.37 | 50.23B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.04 | 44.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.51 | 37.17B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
490.83 | 21.69B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-03-12 | Iniziato | JP Morgan | Overweight |
| 2024-12-11 | Iniziato | Leerink Partners | Outperform |
| 2024-10-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-15 | Iniziato | CapitalOne | Overweight |
| 2023-08-22 | Reiterato | H.C. Wainwright | Buy |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-02 | Iniziato | Truist | Buy |
| 2020-05-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
| 2019-05-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Reiterato | Canaccord Genuity | Buy |
| 2017-07-31 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-22 | Downgrade | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Iniziato | Raymond James | Strong Buy |
| 2016-05-24 | Downgrade | Standpoint Research | Buy → Hold |
| 2015-11-13 | Iniziato | Standpoint Research | Buy |
| 2015-09-28 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Reiterato | Oppenheimer | Outperform |
| 2015-08-04 | Reiterato | ROTH Capital | Neutral |
| 2015-07-31 | Reiterato | Oppenheimer | Outperform |
| 2015-07-15 | Reiterato | ROTH Capital | Neutral |
| 2015-06-23 | Reiterato | Oppenheimer | Outperform |
| 2015-05-18 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Reiterato | Oppenheimer | Outperform |
| 2015-04-10 | Downgrade | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Reiterato | ROTH Capital | Buy |
| 2015-02-18 | Reiterato | Oppenheimer | Outperform |
Mostra tutto
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
How ANI Pharmaceuticals Inc. stock reacts to global recession fears2025 Growth vs Value & Reliable Breakout Stock Forecasts - ulpravda.ru
Is ANI Pharmaceuticals Inc. (BSFA) stock a defensive play amid uncertainty2025 EndofYear Setup & Expert Verified Stock Movement Alerts - ulpravda.ru
How ANI Pharmaceuticals Inc. stock performs in weak economyWeekly Stock Summary & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
What earnings margins imply for ANI Pharmaceuticals Inc. (BSFA) stockJuly 2025 Spike Watch & Consistent Return Investment Signals - ulpravda.ru
ANI Pharmaceuticals (NASDAQ:ANIP) Lowered to "Hold" Rating by Zacks Research - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Nasdaq Today Specialty Pharma Focus - Kalkine Media
Is ANI Pharmaceuticals (ANIP) Price Justified After Updated 2025 Revenue Guidance? - Yahoo Finance
ANI Pharmaceuticals, Inc. CEO Nikhil Lalwani to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
ANIP Up 21% in 6 Months: Is It Worth Investing in the Stock Now? - Your Wyoming Link
ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Healthcare Gem with 38.89% Upside Potential - DirectorsTalk Interviews
3 Reasons to Avoid ANIP and 1 Stock to Buy Instead - Finviz
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2024 Earnings Call Transcript - MSN
2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue - Star Tribune
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Revenue per share of ANI Pharmaceuticals, Inc. – MUN:BSFA - TradingView — Track All Markets
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - The Globe and Mail
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - The Motley Fool
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Rice Hall James & Associates LLC - MarketBeat
Assessing ANI Pharmaceuticals (ANIP) Valuation After a Strong Yearly Share Price Rally - Yahoo Finance
ANI Pharma stock pullback tied to Cortrophin guidance uncertainty - Investing.com
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Trading Down 3.6% on Insider Selling - MarketBeat
ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards? - MSN
Will ANI Pharmaceuticals Inc. stock attract ESG investorsMarket Trend Summary & AI Powered Market Entry Ideas - Улправда
ANI Pharmaceuticals (NASDAQ:ANIP) SVP Sells $133,652.80 in Stock - MarketBeat
ANI Pharmaceuticals Executive Sells Shares - TradingView — Track All Markets
VP Davis Sells 1,622 ($133.7K) Of ANI Pharmaceuticals Inc [ANIP] - TradingView — Track All Markets
Squarepoint Ops LLC Takes $2.14 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Can ANI Pharmaceuticals Inc. stock rebound after recent weaknessQuarterly Trade Review & Daily Oversold Bounce Ideas - DonanımHaber
Is ANI Pharmaceuticals Inc. stock trading at a premium valuationWeekly Gains Summary & Weekly Watchlist for Hot Stocks - Улправда
Can ANI Pharmaceuticals Inc. stock deliver consistent earnings growthJuly 2025 Recap & Safe Capital Growth Tips - Улправда
ANI Pharmaceuticals (ANIP): Assessing Valuation After Recent Share Price Momentum - Sahm
Zacks Industry Outlook Arcutis, Amicus and ANI - The Globe and Mail
Why ANI Pharmaceuticals Inc. stock attracts high net worth investorsJuly 2025 Chart Watch & Fast Gaining Stock Reports - Улправда
FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug - Finviz
Is ANI Pharmaceuticals Stock Price Justified After 47% 2025 Rally? - Yahoo Finance
How Investors May Respond To ANI Pharmaceuticals (ANIP) Creating a Retina-Focused FutureVision Advisory Council - Yahoo Finance
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance
Ranger Investment Management L.P. Reduces Stock Holdings in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Implied volatility surging for ANI Pharmaceuticals stock options - MSN
ANI Pharmaceuticals (NASDAQ:ANIP) VP Sells $32,928.00 in Stock - MarketBeat
ANI Pharmaceuticals Senior VP Meredith Cook Sells 400 Shares - TradingView — Track All Markets
ANI Pharmaceuticals (ANIP) officer Meredith Cook sells 400 shares via 10b5-1 plan - Stock Titan
ANI Pharmaceuticals price target raised to $115 from $114 at Guggenheim - MSN
ANI Pharmaceuticals (ANIP): Assessing Valuation After a Strong Year and Recent Share Price Pullback - Sahm
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards? - MSN
Implied Volatility Surging for ANI Pharmaceuticals Stock Options - Nasdaq
ANI Pharmaceuticals Completes Mandatory Conversion of Preferred Shares - MSN
ANI Pharmaceuticals Director Sold $146K In Company Stock - Benzinga
Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.41%
1.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):